Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 278, doi. 10.1038/sj.tpj.6500463
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2008 AND VI 8 AND IP 4
Results: 7
1
2
ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 289, doi. 10.1038/sj.tpj.6500465
- By:
- Publication type:
- Article
3
Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 297, doi. 10.1038/sj.tpj.6500467
- By:
- Publication type:
- Article
4
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 248, doi. 10.1038/sj.tpj.6500472
- By:
- Publication type:
- Article
5
The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 256, doi. 10.1038/sj.tpj.6500476
- By:
- Publication type:
- Article
6
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 268, doi. 10.1038/sj.tpj.6500482
- By:
- Publication type:
- Article
7
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
- Published in:
- Pharmacogenomics Journal, 2008, v. 8, n. 4, p. 237, doi. 10.1038/sj.tpj.6500487
- By:
- Publication type:
- Article